Introduction
============

N-terminal acetylation has been extensively studied in yeast and humans and represents one of the most common protein modifications in eukaryotes, occurring on approximately 57% of yeast proteins and 84% human proteins \[[@B1]\], although it is rare in prokaryotes. Eukaryotic proteins initiate with methionine residues, which are cleaved from nascent chains if the penultimate residue has a radius of gyration of 1.29 Å or less \[[@B2]\]. *N*-terminal acetylation subsequently occurs on certain of the proteins, either containing or lacking the methionine residue, as depicted in Fig. [1](#F1){ref-type="fig"}. The salient features of *N*-terminal acetylation are summarized in Table [1](#T1){ref-type="table"} and Fig. [2](#F2){ref-type="fig"}. Detailed reviews on the N-terminal acetyltransferases have appeared \[[@B3]-[@B7]\], and the N-terminal acetylation status of 742 human and 616 yeast protein N-termini have been compiled \[[@B1]\]. The wide range and diversity of substrates is due in part to the large number of different *N*-terminal acetylating enzymes, NatA-NatE. The sequence requirements for *N*-terminal acetylation vary with the *N*-terminal acetyltransferase. Only two amino acid residues, Met-Asn-, Met-Asp-, or Met-Glu-, are required for at least partial *N*-terminal acetylation by NatB \[[@B1],[@B8]\]. On the other hand, 30 to 50 specific amino acids are required for *N*-terminal acetylation by NatD \[[@B9]\]. Each of the three major *N*-terminal acetyltransferases, NatA, NatB and NatC, contain a catalytic subunit, and one or two auxiliary subunits (Table [1](#T1){ref-type="table"}). The sequence and functions of the yeast and human orthologous subunits are obviously related. A yeast *ard1*-Δ *nat1*-Δ strain was phenotypically complemented by h*ARD1*h*NAT1*, suggesting that yNatA and hNatA are similar. However, heterologous combinations, h*ARD1*y*NAT1*and y*ARD1*h*NAT1*, were not functional in yeast, suggesting significant structural subunit differences between the species \[[@B1]\].

###### 

Revised nomenclature for N-terminal acetyltransferases

  Type                         NatA                                                             NatB          NatC       NatD             NatE
  ---------------------------- ---------------------------------------------------------------- ------------- ---------- ---------------- --------
  Original                                                                                                                                
   Catalytic subunit           Ard1p                                                            Nat3p         Mak3p      Nat4p            Nat5p
   Auxiliary subunit           Nat1p                                                            Mdm20p        Mak10p                      †
                                                                                                              Mak31p                      
                                                                                                                                          
  Revised                                                                                                                                 
   Catalytic subunit           Naa10p                                                           Naa20p        Naa30p     Naa40p           Naa50p
   Auxiliary subunit           Naa15p                                                           Naa25p        Naa35p                      †
                                                                                                              Naa38p                      
                                                                                                                                          
  Number of yeast substrates   \~2,000                                                          \~1,000       \~250      2?               ?
                                                                                                                                          
  Substrates\*                 Ser-                                                             Met-Glu-      Met-Ile-   Ser-Gly-*etc*-   ?
                               Ala-                                                             Met-Asp-      Met-Leu-                    
                               Gly-                                                             Met-Asn-      Met-Trp-                    
                               Thr-                                                                           Met-Phe-                    
                               Val-‡                                                                                                      
                               Cys-¶                                                                                                      
                               \-\-\-\-\-\-\-\-\-\-\--2 to 8 amino acids\-\-\-\-\-\-\-\-\-\--   30--50 a. a   ?                           

Naa50p is inferred to be an N-terminal acetyltransferase because of its sequence homology to known NATs.

\* Acetylation occurs at least partially on all proteins with Met-Glu-, Met-Asp- and Met-Asn- termini, but only on subclasses of proteins with the other termini.

† Naa15p may be an auxiliary subunit of NatE, as well as an auxiliary subunit of NatA.

‡ Found in humans but not yeast (see Figure 2 legend).

¶One example found in yeast (see Figure 2 legend).

![**A summary of the major pathways of *N*-terminal processing in eukaryotes, showing the four different termini**. 1: Uncleaved and unacetylated Met-Xxx- N-termini; 2: Cleaved and unacetylated Xxx-N-termini; 3: Uncleaved and NatB/NatC acetylated Ac-Met-Xxx- N-termini; 4: Cleaved and NatA acetylated Ac-Xxx-N-termini. See Table 1 and Figure 2 for more detail.](1753-6561-3-S6-S2-1){#F1}

![**The major pathways of *N*-terminal processing in eukaryotes**. Two methionine aminopeptidases (MAP), Map1p and Map2p, cleave *N*-terminal methionine residues that have small side chains (glycine, alanine, serine, cysteine, threonine, proline, and valine), although methionine is retained on some proteins having penultimate residues of valine. Subsequently, NatA, NatB, and NatC acetylate specific sequences as shown in the figure and in Table 1. Acetylation occurs at least partially on all proteins with Met-Glu-, Met-Asp- and Met-Asn- termini, but only on subclasses of proteins with the other termini. For example, acetylation occurs at least partially on 43% of proteins in yeast and on 96% of proteins in humans with Ala- termini. In addition, Ac-Cys-, Ac-Val-, Ac-Met-Met-, and Ac-Met-Lys- termini occurs on some proteins from humans but not from yeast; it is unknown which NATs are responsible for Ac-Cys-, Ac-Met-Met-, and Ac-Met-Lys- acetylations.](1753-6561-3-S6-S2-2){#F2}

Nomenclature
============

During a recent international meeting on N-terminal acetylation, it was pointed out that there is critical need to revise the gene symbols encoding the N-terminal acetyltransferases. The main reason for changing the nomenclature is so that each of the orthologous genes from different species would have the same name. Furthermore, orthologous genes were assigned not only by similarity of their sequences, but also by their action on the same set of proteins. Yeast NatA and human NatA were shown to acetylate the same set proteins by comparing a normal yeast strain with the mutant *naa10*-Δ *naa15*-Δh*NAA10*h*NAA15*\[[@B1]\].

The use of the different symbols *NAT*, *ARD*, *MDM*, and *MAK*is confusing, and does not provide useful information, especially when applied to human NATs. We believe it can be misleading to assign a gene symbol based on one phenotype of a mutant when a large number of proteins are affected, and when the mutant is pleiotropic.

Most importantly, different orthologous genes should have different names. The symbols *NAT1*, *NAT2*and *NAT3*denote human genes encoding arylamine N-acetyltransferases, which are distinct from N-terminal acetyltransferases \[[@B10]\]. On the other hand, NCBI has designated the human homologue of the yeast *NAT*genes as follows: y*NAT1*designated as h*NARG1*; y*NAT3*designated as h*NAT5*; and y*NAT5*designated as h*NAT13*. Also, *ARD1*is used to describe the ADP-ribosylation factor domain protein 1 \[[@B11]\].

Therefore, in this paper we have introduced a new nomenclature for protein *N*-terminal acetyltransferases in eukaryotes (Table [1](#T1){ref-type="table"}). It is important to note that *NAA*([Nα ac]{.ul}etyltransferases) is not used to designate any other gene in yeast or higher eukaryotes. We have assigned each of the subunits of the NatA-NatE complexes a Naa symbol, as presented in Table [1](#T1){ref-type="table"}. We have also recommended a nomenclature for paralogs of human NatA complexes containing either Naa10p or Naa11p in combination with either Naa15p or Naa16p (Table [2](#T2){ref-type="table"}). The revised symbols, along with synonyms from yeast and humans, are presented in Table [3](#T3){ref-type="table"}. Clearly, this revised nomenclature will greatly diminish the confusion in describing orthologous subunits from different species.

###### 

Paralogs

  Subunit                            Complex
  ---------------------------------- ----------------------------------------------------
  Catalytic subunit Naa10p, Naa11p   
                                     NatA(10+15); NatA(10+16); NatA(11+15); NatA(11+16)
  Auxiliary subunit Naa15p, Naa16p   

Almost all human NAT subunit genes encode alternative splicing isoforms whose functions are in question, and are not considered here.

###### 

Synonyms

                                      Accession no.            
  -------- -------------------------- --------------- -------- --------------------------
  Naa10p   Ard1p; TE2                 P07347          P41227   \[[@B12]-[@B14]\]
  Naa11p   Ard2p                      \-              Q9BSU3   \[[@B15]\]
  Naa15p   Nat1p; NARG1; NATH; TBDN   P12945          Q9BXJ9   \[[@B16]-[@B20]\]
  Naa16p   Nat2p; NARG1L              \-              Q6N069   \[[@B20],[@B21]\]
  Naa20p   Nat3p; hNat5p              Q06504          P61599   \[[@B8],[@B22],[@B23]\]
  Naa25p   Mdm20p; p120               Q12387          Q14CX7   \[[@B8],[@B23]\]
  Naa30p   Mak3p; hNat12p             Q03503          Q147X3   \[[@B24]-[@B26]\]
  Naa35p   Mak10p; hEGAP              Q02197          Q5VZE5   \[[@B24],[@B25],[@B27]\]
  Naa38p   Mak31p; hLsm8p             P23059          O95777   \[[@B24],[@B25],[@B27]\]
  Naa40p   Nat4p; hNat11p             Q04751          Q86UY6   \[[@B28]\]
  Naa50p   Nat5p; hNat13p; San        Q08689          Q9GZZ1   \[[@B29]-[@B31]\]

An example of standard symbols: Protein, Naa10p; Gene, *NAA10*; Deleted gene, *naa10-Δ*. hNaa10p, human; yNaa10p, yeast (*S. cerevisiae*); mNaa10p, mouse.
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